Boron-containing small molecules

Details for Australian Patent Application No. 2006214247 (hide)

Owner Anacor Pharmaceuticals, Inc.

Inventors Baker, Stephen J.; Leyden, James J.; Hold, Karin M.; Maples, Kirk R.; Akama, Tsutomu; Hernandez, Vincent S.; Zhang, Yong-Kang; Plattner, Jacob J.; Sanders, Virginia; Fieldson, Gregory

Agent Allens Arthur Robinson

Pub. Number AU-B-2006214247

PCT Pub. Number WO2006/089067

Priority 60/654,060 16.02.05 US

Filing date 16 February 2006

Wipo publication date 24 August 2006

Acceptance publication date 5 August 2010

International Classifications

C07D 307/77 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/089067 Priority application(s): WO2006/089067

1 April 2010 Amendment Made

  The nature of the amendment is: Delete the co-inventor Bellinger-Kawahara, Carolyn. Add the co-inventor Fieldson, Gregory

5 August 2010 Application Accepted

  Published as AU-B-2006214247

2 December 2010 Standard Patent Sealed

5 July 2012 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 14 Jun 2012 . Address for service in Australia - Allens Patent & Trade Mark Attorneys Level 28 Deutsche Bank Place Corner Hunter and Phillip Streets Sydney NSW 2000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006214249-Smart joint implant sensors

2006214244-Methods for treating lymphomas using a combination of a chemotherapeutic agent and IL-2 and optionally an antiCD20 antibody